Home/Filings/4/0001628280-25-010437
4//SEC Filing

Rubin Jonathan 4

Accession 0001628280-25-010437

CIK 0001356576other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 4:14 PM ET

Size

7.8 KB

Accession

0001628280-25-010437

Insider Transaction Report

Form 4
Period: 2025-03-05
Rubin Jonathan
SVP, Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2025-03-05$33.05/sh314$10,37810,789 total
  • Tax Payment

    Common Stock

    2025-03-05$33.05/sh577$19,07010,212 total
  • Tax Payment

    Common Stock

    2025-03-05$33.05/sh577$19,0709,635 total
Footnotes (1)
  • [F1]Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Restricted Stock Units.

Issuer

SUPERNUS PHARMACEUTICALS, INC.

CIK 0001356576

Entity typeother

Related Parties

1
  • filerCIK 0001836067

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:14 PM ET
Size
7.8 KB